Abstract:In mammals, oleic acid (OA) induces pulmonary edema (PE), which can initiate acute lung injury (ALI) and lead to acute respiratory distress syndrome (ARDS). Pulmonary surfactant (PS) plays a key role in a broad range of treatments for ARDS. The aim of the present investigation was to assess changes in the synthesis of phosphatidylcholine (PC) from choline and determine the effect of exogenous PS on its de novo synthesis in rats with OA-induced PE. Experimental rats were randomized into three groups, including a control group, OA-induced PE group, and OA-induced group treated with exogenous PS (OA-PS). Twenty-four rats were sacrificed 4 h after induction of the OA model, and tissue was examined by light and electron microscopy to assess the severity of ALI using an established scoring system at the end of the experiment. After 15 μCi 3H-choline chloride was injected intravenously, eight rats in each group were sacrificed at 4, 8, and 16 h. The radioactivity of 3H incorporated into total phospholipid (TPL) and desaturated phosphatidylcholine (DSPC) was measured in bronchoalveolar lavage fluid (BALF) and lung tissue (LT) using a liquid scintillation counter and was expressed as counts per minute (CPM). Results showed that TPL, DSPC, and the ratio of DSPC/total protein (TP) in lung tissue decreased 4 h after challenge with OA, but the levels recovered after 8 and 16 h. At 8 h after injection, 3H-TPL and 3H-DSPC radioactivity in the lungs reached its peak. Importantly, 3H-DSPC CPM were significantly lower in the PS treatment group (LT: Control: 62327 ± 9108; OA-PE: 97315 ± 10083; OA-PS: 45127 ± 10034, P < 0.05; BALF: Control: 7771 ± 1768; OA-PE: 8097 ± 1799; OA-PE: 3651 ± 1027, P < 0.05). Furthermore, DSPC secretory rate (SR) in the lungs was significantly lower in the PS treatment group at 4 h after injection (Control: 0.014 ± 0.003; OA-PE: 0.011 ± 0.004; OA-PS: 0.023 ± 0.006, P < 0.05). Therefore, we hypothesize that exogenous PS treatments may adversely affect endogenous de novo synthetic and secretory phospholipid pathways via feedback inhibition. This novel finding reveals the specific involvement of exogenous PS in endogenous synthetic and secretory phospholipid pathways during the treatment of ARDS. This information improves our understanding of how PS treatment is beneficial against ARDS and opens new opportunities for expanding its use.

Oxysterols Inhibit Phosphatidylcholine Synthesis Via Erk Docking and Phosphorylation of Ctp : Phosphocholine Cytidylyltransferase

The Formation of Phosphatidylcholine Oxidation Products by Stimulated Phagocytes

Synthesis of phosphatidylcholine in rats with oleic acid-induced pulmonary edema and effect of exogenous pulmonary surfactant on its De Novo synthesis

Retraction: CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke.

CDP‐CHOLINE PARTLY RESTORES THE PHOSPHATIDYLCHOLINE LEVELS BY DIFFERENTIALLY AFFECTING SECRETORY PHOSPHOLIPASE A <sub>2</sub> IIA AND CTP‐PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE AFTER STROKE

CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke.

Synthesis of Phosphatidylcholines in Ozone-Exposed Alveolar Type II Cells Isolated from Adult Rat Lung: Is Glycerolphosphate Acyltransferase a Rate-Limiting Enzyme?

Oxysterols Protect Epithelial Cells Against Pore-Forming Toxins

In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome

Hydrogenated Soy Phosphatidylcholine Liposomes Stimulate Differential Expression of Chemokines And Cytokines by Rat Alveolar Macrophages In Vitro

Sulfated Oxysterol, 25hc3s, is A Potent Regulator of Lipid Metabolism in Human Hepatocytes

Differential contributions of phosphotransferases CEPT1 and CHPT1 to phosphatidylcholine homeostasis and lipid droplet biogenesis

Biosynthesis of the regulatory oxysterol, 5-cholesten-3β,25-diol 3-sulfate, in hepatocytes

Oxycholesterol Protects Against LXR‐mediated Steatosis Through Epstein‐Barr Virus‐induced GPCR 2 (EBI2) in Human and Mouse Hepatocytes

Characterization of phospholipid-modified lung surfactant in vitro and in a neonatal ARDS model reveals anti-inflammatory potential and surfactant lipidome signatures

Lysosomal Acid Lipase Over‐expression Disrupts Lamellar Body Genesis and Alveolar Structure in the Lung

Adsorption of surfactant to bronchial epithelium: possible role of receptor 'unmasking' in asthma.

Oxysterols in Cell Viability, Phospholipidosis and Extracellular Vesicles Production in a Lung Cancer Model

Cooperative induction of CXCL chemokines by inflammatory cytokines and oxidized phospholipids

PC (16:0/14:0) Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia by Upregulating Claudin-1 and Promoting Alveolar Type II Cell Repair

Phospholipase-catalyzed degradation drives domain morphology and rheology transitions in model lung surfactant monolayers